Does Aetna Cover Wegovy? 2026 Coverage Rules, Costs, and How to Get Approved

The 90-second answer (find your situation)

No prescription required. Ro contacts your insurer and sends back a personalized coverage report.

Does Aetna cover Wegovy?

Aetna covers Wegovy on many commercial plans, but it is never automatic. When an Aetna plan covers weight-loss medication, Wegovy is usually the GLP-1 it covers, because Wegovy holds preferred status on CVS Caremark’s standard commercial drug list. The catch is that some employer plans exclude weight-loss drugs entirely, and even when Wegovy is covered, you’ll need prior authorization — your insurer’s sign-off before they’ll pay.

• →"Yes, probably" is not the same as "guaranteed."
• →"On the drug list" is not the same as "your plan pays for it."
• →"Covered" is not the same as "cheap."
• →"Needs prior authorization" is not the same as "denied."

Why so many Aetna plans cover Wegovy

Many Aetna pharmacy benefits run through a pharmacy benefit manager (PBM) — the company that builds the covered-drug list — and Aetna’s PBM is CVS Caremark.

In July 2025, CVS Caremark made Wegovy the preferred GLP-1 on its standard commercial drug list and dropped its rival, Zepbound, after a pricing deal with Wegovy’s maker, Novo Nordisk. That standard list covers roughly 25 million to 30 million Americans. So on plans that follow that standard list and cover weight-loss drugs, Wegovy became the GLP-1 your plan wants you on.

That’s why “does Aetna cover Wegovy” so often ends in “yes.” But “often” isn’t “always” — and here’s the part that decides your case.

The catch nobody puts in the headline

CVS Caremark sets a standard list, but your employer or union can customize it — or skip weight-loss coverage altogether. Preferred status only helps if your plan covers the category in the first place.

KFF’s 2025 Employer Health Benefits Survey found that only about 19% of large firms (200+ workers) cover GLP-1 drugs for weight loss, 57% don’t, and about 24% aren’t sure. Bigger companies are more generous — 43% of firms with 5,000+ workers cover them — but it’s far from a sure thing.

So the honest version: Aetna covers Wegovy on plans that include weight-loss drugs — and on those plans, Wegovy is usually the preferred pick. The variable is whether your specific plan covers the category at all.

The RX Index Aetna Wegovy Coverage Map (2026)

Last verified June 13, 2026. Aetna’s drug coverage runs largely through CVS Caremark; your employer’s plan design can override these defaults.

Find out which plan you have in 5 minutes →

Why the answer is so confusing: the 5 layers of Aetna coverage

Aetna coverage feels confusing because “Aetna” isn’t one rule — it’s at least five separate checkpoints, and a drug can pass one while failing another. A medication can appear on an Aetna drug list and still be excluded by your employer, or be “covered” but cost full price until your deductible is met. Knowing which layer is blocking you tells you whether to fight, switch, or pay smart.

Think of it as five doors. Wegovy has to clear all five to land in your hands at a price you like.

“Listed” is not “covered” (the trap that wastes the most time)

Aetna’s published drug guides say so themselves. Aetna’s standard drug list notes it isn’t all-inclusive, that it updates monthly, and that your specific plan may not cover a drug even when it appears in the document. People see “Wegovy” in a PDF, assume they’re set, and then get blindsided at the pharmacy.

The one honest catch, up front

If your employer’s plan flatly excludes weight-loss drugs, Aetna is probably the wrong path for a weight-loss prescription — and a stronger doctor’s letter won’t fix a benefit exclusion. Aetna’s own medical policy is blunt: many plans specifically exclude weight-reduction medications, and claims get denied under that exclusion no matter the medical need.

But that’s exactly why checking the exclusion first is the smartest five minutes you’ll spend. If the door’s closed, you stop wasting time on the wrong fight and pivot straight to the paths that still work — an appeal, an HR benefits request, the Medicare GLP-1 Bridge if you’re on Medicare, or a verified self-pay route.

What does Aetna require to approve Wegovy in 2026?

Aetna requires prior authorization for Wegovy, and the BMI bar depends on which policy your plan uses — so don’t guess it. Aetna’s Wegovy prior-authorization policy (4774-C) follows the FDA label: a starting BMI of 30 or higher, or 27 or higher with a weight-related condition like high blood pressure, type 2 diabetes, or high cholesterol. A separate 2026 Aetna policy titled “Weight Loss (BMI 35)” may apply a higher BMI ≥35 bar. Most weight-loss approvals also require documentation that you’ve tried a structured weight program for about six months.

Two BMI numbers — confirm which one is yours

This is where people trip. Aetna has more than one policy that can govern a Wegovy request, and they don’t all use the same BMI cutoff:

• Aetna’s Wegovy PA policy (4774-C) uses the FDA-label numbers: BMI ≥30, or ≥27 with a weight-related condition.
• A separate 2026 policy titled “Weight Loss (BMI 35)” points to a higher BMI ≥35 bar for approving GLP-1s for weight loss.

Both are real Aetna documents. Someone with a BMI of 32 could read a generic article, assume “I qualify,” and then get denied on a plan that requires 35. Don’t guess the rule — ask Aetna or CVS Caremark for the PA policy ID tied to your plan.

Which Aetna Wegovy policy applies to my plan?

Ask Aetna or CVS Caremark for the policy ID behind your Wegovy prior authorization, and don’t rely on a random Aetna PDF — different Aetna policies use different BMI thresholds and continuation rules. The crosswalk below lines them up.

Aetna Wegovy policy crosswalk (verified June 13, 2026)

What Aetna’s weight-management criteria typically include

What happens at renewal

Getting approved once isn’t the finish line. Under Aetna’s Wegovy PA policy (4774-C), keeping coverage can require that you’ve been on a stable maintenance dose for at least 3 months and lost at least 5% of your starting body weight (or held that loss). Your plan may use different criteria, so confirm the policy ID — and keep your weigh-ins documented so your renewal sails through.

Does Aetna cover Wegovy for heart disease or other conditions?

Yes — Aetna may cover Wegovy under a separate cardiovascular pathway, and the rules differ from a weight-loss request. For adults with established heart disease plus overweight or obesity, Aetna can approve Wegovy to lower the risk of a major cardiovascular event — an FDA-approved use since March 2024. This pathway uses a BMI of 27+ with specific heart-history documentation, and it generally doesn’t require the 6-month weight program.

The cardiovascular pathway may fit if you have:

• A prior heart attack
• A prior stroke
• Symptomatic peripheral artery disease (poor blood flow in the legs)
• A history of a heart procedure like bypass, stent, or angioplasty
• A BMI of 27 or higher
• No type 2 diabetes (Aetna generally routes diabetes-plus-heart-disease patients to a different drug, like Ozempic)

If that’s your picture, ask your prescriber whether Wegovy should be requested for cardiovascular risk reduction rather than (or alongside) weight loss. It’s a real, FDA-approved indication — not a loophole — and it’s judged on its own merits.

Wegovy for MASH (serious liver disease)

Aetna’s policy also includes a pathway for Wegovy injection to treat non-cirrhotic MASH (metabolic dysfunction-associated steatohepatitis, a serious fatty-liver disease formerly called NASH) with moderate-to-advanced scarring (F2–F3 fibrosis). Two things to know:

1. This MASH indication is approved under FDA “accelerated approval,” based on improvement of MASH and fibrosis — meaning continued approval may depend on a confirmatory trial.
2. It’s the injection only (not the pill or Wegovy HD), it needs a liver or GI specialist involved, and it requires documented fibrosis staging.

A quick safety note before we go further

How do I check if MY exact Aetna plan covers Wegovy?

The fastest reliable answer comes from your own Aetna member account, your plan documents, or the number on your insurance card. Aetna lets members log in to see personalized coverage, drug tier, prior authorization rules, and pricing for their specific plan. The general drug guide on the public website isn’t enough, because it can’t see your plan’s exclusions.

The 5-minute Aetna lookup

1. Log in to your Aetna member account (web or app).
2. Go to Prescriptions or Pharmacy.
3. Search “Wegovy” (and try “semaglutide,” the active ingredient).
4. Check four things: Is it covered? What tier? Does it need prior authorization? Are there quantity limits or step therapy?
5. Screenshot the result so you have it in writing.

The phone script (copy, paste, read it out loud)

Call the member-services number on your card and say:

“I’m checking coverage for Wegovy under my pharmacy benefit. Can you tell me: Is Wegovy covered on my plan? Does my plan exclude weight-loss medications? Is prior authorization required, and which policy or criteria apply? What tier is it, and are there quantity limits? And what would my estimated cost be — before and after my deductible?”

The HR script (for employer plans)

If you get insurance through work, email your benefits contact:

“Does our Aetna plan cover anti-obesity medications under the pharmacy benefit, or is there a weight-loss drug exclusion? If it’s excluded, is there an exception process or an upcoming benefits review?”

How much does Wegovy cost with Aetna?

Wegovy’s cost with Aetna swings from a small copay to a four-figure bill, depending on coverage, your deductible, and savings-card eligibility. With commercial coverage, eligible patients can pay as little as $25 a month using Novo Nordisk’s savings card. Without coverage, Wegovy’s list price is about $1,349 a month, but Novo Nordisk’s own self-pay pharmacy charges far less.

Verified Wegovy prices (last checked June 13, 2026)

How the savings card works

If your commercial (non-government) Aetna plan covers Wegovy, Novo Nordisk’s savings card can drop your cost to as little as $25 a month, covering up to $100/month. You can’t use it if you’re on Medicare, Medicaid, or TRICARE — that’s federal law, not Aetna’s choice. Enroll at the NovoCare/Wegovy site once your prescription is approved.

HSA/FSA

Many people use HSA or FSA funds (tax-free health spending accounts) for Wegovy with a prescription. If you have one of those accounts, confirm eligibility with your plan administrator — it can effectively shave off whatever your tax rate is.

Why does Aetna say Wegovy is “covered” but the pharmacy wants $1,300?

Because “covered” and “affordable” are two different things. When a plan covers Wegovy but you haven’t met your deductible — or the drug sits on a high cost-sharing tier — you can be asked to pay the full or near-full price even though it’s technically covered. This is cost-sharing, not a denial, and the fix is different.

This is the most heartbreaking moment in the whole process: the PA gets approved, you celebrate, you walk into the pharmacy — and the register says $1,300. It usually isn’t a mistake. It’s one of these:

• Your deductible isn’t met yet. Until it is, you may pay the plan’s negotiated price.
• Coinsurance on a high list price. “20% coinsurance” of $1,349 is still a lot.
• Wegovy is on a non-preferred tier on your specific plan.
• The pharmacy is out of network.
• A coupon wasn’t applied, or you weren’t eligible for it.

The questions that decode the bill

Why did Aetna deny my Wegovy — and how do I fix it?

Most Aetna Wegovy denials fall into two buckets: fixable paperwork problems and hard plan exclusions. Missing BMI records, no proof of a 6-month weight program, the wrong indication, or an incomplete PA form are usually fixable on appeal. A true weight-loss drug exclusion is much harder to overturn — so the very first thing to do is read the denial and figure out which bucket you’re in.

The denial-letter decoder

The 7-step denial action plan

1. Get the denial letter (call and ask them to send it if you don’t have it).
2. Highlight the exact reason for the denial.
3. Ask: is this a benefit exclusion or a medical-necessity denial? (This decides everything.)
4. Match the denial to Aetna’s criteria — which box did the PA miss?
5. Gather the missing proof: BMI, weight history, conditions, your 6-month program records, and any heart/liver documentation.
6. Have your prescriber appeal with the specific evidence Aetna asked for.
7. If it’s a true exclusion, stop appealing and pivot — HR request, Medicare Bridge (if eligible), or a verified self-pay route.

What your doctor should put in the packet

Diagnosis and indication · height, weight, BMI with date · weight history · any conditions like high blood pressure or sleep apnea · proof of about 6 months in a weight-management program · prior treatments tried · heart or liver documentation if relevant · a line stating Wegovy is used with a reduced-calorie diet and more activity · your 5% weight-loss proof if it’s a renewal.

Does Aetna Medicare cover Wegovy?

Aetna Medicare is a different world from commercial Aetna. By federal law, regular Medicare Part D can’t cover GLP-1s for weight loss alone — but a temporary federal program, the Medicare GLP-1 Bridge, gives eligible Part D members Wegovy for a flat $50 monthly copay from July 1, 2026 through December 31, 2027. And if you have established heart disease, Wegovy may already be covered under Part D for that separate, FDA-approved cardiovascular use.

What to know about the Bridge

Per CMS:

• It runs July 1, 2026 – December 31, 2027. Nothing is processed before July 1, 2026, and you don’t need to register now.
• It operates outside your Part D plan — a central system run by Medicare handles approvals, claims, and payments.
• Eligible plan types: a standalone Part D drug plan (PDP) or a Medicare Advantage coordinated-care plan with drug coverage (MA-PD), plus certain Special Needs Plans, employer/union group plans, and LI NET. Not every Medicare Advantage plan automatically qualifies.
• Eligible drugs (for weight loss): Foundayo, Wegovy (injection and tablets), and Zepbound KwikPen — the Zepbound single-dose vial and pen are not included.
• A flat $50 copay. The $50 doesn’t count toward your Part D deductible or your yearly out-of-pocket cap.

Who qualifies — you must be 18+ and meet one of three tiers:

1. BMI ≥ 35 on its own, or
2. BMI ≥ 30 with heart failure with preserved ejection fraction, uncontrolled high blood pressure, or chronic kidney disease stage 3a or above, or
3. BMI ≥ 27 with prediabetes, a previous heart attack, a previous stroke, or symptomatic peripheral artery disease.

One more rule: if you already qualify for Wegovy under a Part D-covered use (heart disease), you get it through your plan — not the Bridge. And the Wegovy savings card does not work for anyone on Medicare or Medicaid (federal law). If you’re on Aetna Medicare, the Bridge is likely your cleanest weight-loss path starting this summer.

Does Aetna Better Health (Medicaid) cover Wegovy?

Medicaid coverage is set state by state — and in 2026, several states are cutting GLP-1 coverage for weight loss. Aetna Better Health plans follow each state’s Medicaid rules, so there’s no national yes-or-no.

• California (Medi-Cal): As of January 1, 2026, Wegovy, Zepbound, and Saxenda are no longer covered for weight loss. Wegovy can still be covered for MASH or cardiovascular disease; Zepbound for sleep apnea.
• Massachusetts (MassHealth): Effective July 1, 2026, the program stops covering anti-obesity drugs for weight loss. Coverage continues only for specific medically accepted conditions.

The takeaway: check your state’s current Medicaid drug list, because the rules are changing fast and differ in every state. Note — Ro and most telehealth concierges can’t coordinate Medicaid coverage, and Medicaid members generally can’t pay cash through Ro either.

What if Aetna won’t cover Wegovy, or the cost is too high?

If Aetna won’t cover Wegovy, first figure out why — exclusion, denial, deductible, or wrong pathway — because each has a different best move. Cash prices have dropped a lot — Novo Nordisk’s own pharmacy is $349/month for maintenance doses, far below the ~$1,349 retail price.

The honest cash math

• NovoCare Pharmacy: $349/month for maintenance doses ($199/month intro through June 30, 2026). Same drug, shipped to your door.
• The Wegovy pill (oral): from $149/month for starting tablet doses via Novo’s self-pay.
• TrumpRx (federal direct-pay site, launched February 2026): about $350/month, no insurance needed.

If you want a provider’s help and a one-time visit

For readers who’d rather choose their own clinician or want a one-time video visit instead of a membership, Sesame is our secondary pick for FDA-approved brand-name GLP-1s. Success by Sesame starts as low as $59/month with an annual subscription, medication is separate, and it’s HSA/FSA-eligible.

Best for self-pay shoppers who want provider choice and to see prices before booking.

One note on compounded GLP-1s

You’ll see ads for compounded semaglutide at low prices. Be clear-eyed: compounded semaglutide is not Wegovy and is not FDA-approved Wegovy — it’s a different, custom-mixed product that the FDA does not review for safety, effectiveness, or quality before it’s sold. If brand-name Wegovy truly isn’t workable and you want to weigh other routes with a licensed clinician, see our GLP-1 provider comparison.

Does Aetna cover the Wegovy pill (tablets)?

Maybe — and it depends on your plan and its prior authorization rules. Wegovy tablets are FDA-labeled for adult weight reduction and cardiovascular-risk reduction, and Aetna’s Wegovy policy includes the tablet form, but your specific commercial plan still decides coverage, the BMI/documentation rules, and your cost.

• The tablet may need its own prior authorization, separate from the injection — so ask about both.
• On the insurance route through some telehealth programs, the Wegovy pen is the version offered (the pill is often a cash-pay option). If you specifically want the covered pill, confirm that with your plan and your provider.

If your plan doesn’t cover the tablet, Novo Nordisk’s self-pay price for the Wegovy pill starts at $149/month for the starting doses.

Does Aetna cover Ozempic but not Wegovy?

Ozempic and Wegovy are separate coverage decisions, even though both contain semaglutide. Aetna generally evaluates Ozempic under type 2 diabetes (and heart disease) criteria, while Wegovy is evaluated under weight-management, cardiovascular, or liver-disease pathways. So your plan can absolutely cover one and not the other.

• Type 2 diabetes? Ask about Ozempic or Mounjaro.
• Weight management? Ask about Wegovy (and, after the 2026 changes, Zepbound or Foundayo).
• Established heart disease? Ask about Wegovy’s cardiovascular pathway — or Ozempic if you also have type 2 diabetes.
• MASH (liver disease)? Ask about Wegovy injection.

And again — never let anyone record a diagnosis you don’t have to force a “yes.” Match the request to the real you.

What changed in 2026 for Aetna + Wegovy coverage?

2026 brought real movement: CVS Caremark is expanding GLP-1 options, and Medicare is opening a temporary door. The headline changes: CVS Caremark removed its block on the new oral pill Foundayo on June 1, 2026, will add Zepbound back as a co-preferred option on October 1, 2026, and the Medicare GLP-1 Bridge launches July 1, 2026. Wegovy’s preferred status on the standard list continues.

• June 1, 2026 — Foundayo unblocked. CVS Caremark removed its new-to-market block on Foundayo (orforglipron). See our Aetna + Foundayo coverage page for the current read.
• October 1, 2026 — Zepbound returns. CVS Caremark will add Zepbound back to its standard commercial list as an additional preferred option, making Wegovy and Zepbound co-preferred. The catch is unchanged: employers can still opt out of weight-loss coverage.
• July 1, 2026 — Medicare GLP-1 Bridge. A flat $50/month copay for eligible Medicare members (details above).
• Oral Wegovy is now available. Beyond the familiar pen, there’s now a Wegovy pill, which changes some cash-pay and coverage conversations.

What we actually verified

We’d rather show our work than ask you to take our word for it.

Frequently asked questions

Still deciding? Get a personalized plan.

There’s a lot here, and your situation is yours alone — your plan, your BMI, your budget, your reason for wanting Wegovy. If you’d rather not piece it together solo:

Sources

• Aetna — Weight Reduction Programs and Devices, Clinical Policy Bulletin 0039
• Aetna — Wegovy PA policy 4774-C; Wegovy (Cardiovascular) PA policy 6410-C; Weight Loss (BMI 35) GLP-1/GIP PA policy 6450-C
• Aetna — Find a Medication / member drug search (aetna.com)
• Novo Nordisk / NovoCare — Wegovy cost, coverage, and savings
• U.S. FDA — Wegovy prescribing information, including Boxed Warning
• U.S. FDA — concerns about unapproved/compounded GLP-1s
• CMS — Medicare GLP-1 Bridge, information for beneficiaries
• KFF — 2025 Employer Health Benefits Survey (kff.org)
• CVS Health — GLP-1 weight-management coverage update, May 28, 2026
• Medi-Cal Rx GLP-1 Coverage Considerations
• MassHealth Pharmacy Facts #271 (March 2026)
• Ro — GLP-1 Insurance Coverage Checker, Weight Loss Insurance, and Coverage Checker Report (ro.co)
• Sesame — Success by Sesame weight-loss program (sesamecare.com)